HEMATOPOIETIC STEM CELL TRANSPLANTATION
Clinical trials for HEMATOPOIETIC STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a simple dietary supplement protect transplant patients from a dangerous side effect?
Disease control CompletedThis study tested whether a commercially available potato starch supplement could help prevent a serious complication called graft-versus-host disease (GVHD) in patients receiving a stem cell transplant. Researchers gave the supplement to 107 patients starting just before their t…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Could fish oil help kids recover from cancer treatment?
Disease control CompletedThis study tested if giving children an intravenous (IV) fish oil supplement during a stem cell transplant is safe. The goal was to see if this special nutrition could help control common side effects like inflammation and high blood fats, potentially reducing infections and othe…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE1 • Sponsor: Alexandra N. Carey • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Common drug tested to stop bleeding in blood cancer patients
Disease control CompletedThis study tested whether tranexamic acid, a drug that helps blood clot, could reduce serious bleeding or death in adults with blood cancers who have very low platelet counts from treatment. Over 600 patients were randomly assigned to receive either the drug or a placebo (dummy t…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE3 • Sponsor: NHS Blood and Transplant • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New scan could spare patients from long, toxic treatments
Diagnosis CompletedThis study aimed to see if a special type of PET scan could help doctors better manage a serious fungal infection called hepatosplenic candidiasis. The infection mainly affects the liver and spleen of cancer patients with weakened immune systems. Researchers tested if the scan co…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Mar 31, 2026 12:10 UTC
-
Doctors track new Virus-Fighting drugs in vulnerable transplant patients
Knowledge-focused CompletedThis study observed 400 adult patients who received a stem cell transplant to see how well different anti-CMV drugs worked in real-world hospital settings. The goal was to track how often the drugs prevented or treated CMV infections, if the virus became resistant to the medicati…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:10 UTC
-
Scientists measure how stem cell transplants affect the Body's strength and stamina
Knowledge-focused CompletedThis study aimed to understand how an allogeneic stem cell transplant affects a person's physical fitness. Researchers compared 17 transplant patients to healthy individuals, measuring things like muscle strength, lung function, balance, and activity levels. The goal was to gathe…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: Istinye University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC